Similar articles

• The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer.

  Cunliffe WJ. Cunliffe WJ. Cancer Treat Res. 1991;55:143-59. doi: 10.1007/978-1-4615-3882-0_9. Cancer Treat Res. 1991. PMID: 1681854 Review. No abstract available.
• Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.

  Noh SH, Yoo CH, Chung HC, Roh JK, Shin DW, Min JS. Noh SH, et al. Oncology. 2001;60(1):24-30. doi: 10.1159/000055292. Oncology. 2001. PMID: 11150904
• Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP).

  Arbuck SG, Douglass HO Jr, Nava HR, Silk YN, Baroni M, Rustum YM. Arbuck SG, et al. Adv Exp Med Biol. 1988;244:285-93. doi: 10.1007/978-1-4684-5607-3_31. Adv Exp Med Biol. 1988. PMID: 3073662 Clinical Trial. No abstract available.
• A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.

  Yu W. Yu W. Eur J Surg Oncol. 2006 Aug;32(6):655-60. doi: 10.1016/j.ejso.2006.03.010. Epub 2006 Apr 18. Eur J Surg Oncol. 2006. PMID: 16618532 Review.
• Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

  Atiq OT, Kelsen DP, Shiu MH, Saltz L, Tong W, Niedzwiecki D, Trochanowski B, Lin S, Toomasi F, Brennan M. Atiq OT, et al. J Clin Oncol. 1993 Mar;11(3):425-33. doi: 10.1200/JCO.1993.11.3.425. J Clin Oncol. 1993. PMID: 8445416 Clinical Trial.